Characteristics of oral mucositis in patients undergoing haploidentical stem cell transplantation with posttransplant cyclophosphamide: marked difference between busulfan and melphalan regimens
The risk of oral mucositis in patients undergoing haplo-HSCT with PTCy is highest with the MAC-Bu conditioning regimen, followed by RIC-Bu, and lowest with RIC-Mel.
Authors
- Rumi Miura
- Ken‐ichi Matsuoka (ORCID: https://orcid.org/0000-0001-7955-8266)
- Saki Ogura
- Takuo Kuboki (ORCID: https://orcid.org/0000-0003-3756-2835)
- Yoshihiko Soga (ORCID: https://orcid.org/0000-0001-5346-1474)
- Yoshinobu Maeda (ORCID: https://orcid.org/0009-0004-0051-0075)
- Hideaki Fujiwara (ORCID: https://orcid.org/0000-0002-0734-9315)
Institutions
- Okayama University (JP)
- Okayama University Hospital (JP)
Publication Details
- Journal
- Supportive Care in Cancer
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1007/s00520-025-09313-z
- Citations
- 3
- Primary Topic
- Oral health in cancer treatment
- Type
- article
- Field-Weighted Citation Impact
- 4.56
Funders
- Okayama University